|
|
Post by winstonsmith on Nov 8, 2019 21:14:30 GMT -5
I'll say it again.....CUT THE PRICE FOR AFREZZA IN HALF. Give insurance companies a big reason to cover everyone. Get customers and physicians on board and later raise the price incrementally. Volume Volume Volume means acceptance!!!
|
|
|
|
Post by peppy on Nov 8, 2019 21:23:53 GMT -5
I'll say it again.....CUT THE PRICE FOR AFREZZA IN HALF. Give insurance companies a big reason to cover everyone. Get customers and physicians on board and later raise the price incrementally. Volume Volume Volume means acceptance!!! My understanding, a price cut in half will not give the insurance companies a reason to cover afrezza. RATHER, making a deal with the insurance company, of a 50% kickback to them would probably give the insurance companies reason to cover afrezza. see how that works? |
|
|
|
Post by rfogel on Nov 8, 2019 22:21:25 GMT -5
Any idea how much each afrezza cartridge costs to manufacture?
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 8, 2019 22:26:47 GMT -5
Any idea how much each afrezza cartridge costs to manufacture? Matt Pfeiffer (Old CEO) said at full capacity Afrezza will generate 70% Profit Margins. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 8, 2019 22:29:53 GMT -5
I'll say it again.....CUT THE PRICE FOR AFREZZA IN HALF. Give insurance companies a big reason to cover everyone. Get customers and physicians on board and later raise the price incrementally. Volume Volume Volume means acceptance!!! Your idea will not work. The ADA and Insurance companies has certain protocols and they have to follow them. The only way Afrezza will get clear approval is if they get a new classification. And that would be ULTRA RAPID. Then the insurance companies will cover immediately. Regarding the ADA they have protocols on how diabetics should be treated. Type 2's - Diet & Exercise, Oral Meds, Basal Insulin and then Prandial. By the time you get to prandial 10-13 years have gone by and damage has already taken place in the body. |
|
|
|
Post by winstonsmith on Nov 8, 2019 22:50:35 GMT -5
I'll say it again.....CUT THE PRICE FOR AFREZZA IN HALF. Give insurance companies a big reason to cover everyone. Get customers and physicians on board and later raise the price incrementally. Volume Volume Volume means acceptance!!! Your idea will not work. The ADA and Insurance companies has certain protocols and they have to follow them. The only way Afrezza will get clear approval is if they get a new classification. And that would be ULTRA RAPID. Then the insurance companies will cover immediately. Regarding the ADA they have protocols on how diabetics should be treated. Type 2's - Diet & Exercise, Oral Meds, Basal Insulin and then Prandial. By the time you get to prandial 10-13 years have gone by and damage has already taken place in the body. Thanks Casper very interesting. The PA who treats me as a T2 let me bypass all the other stuff and go straight to Afrezza. She had never heard of it and I had to sell her on it but she was listening and gave it a shot and likes the big decrease in A1C. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 9, 2019 1:12:21 GMT -5
Your idea will not work. The ADA and Insurance companies has certain protocols and they have to follow them. The only way Afrezza will get clear approval is if they get a new classification. And that would be ULTRA RAPID. Then the insurance companies will cover immediately. Regarding the ADA they have protocols on how diabetics should be treated. Type 2's - Diet & Exercise, Oral Meds, Basal Insulin and then Prandial. By the time you get to prandial 10-13 years have gone by and damage has already taken place in the body. Thanks Casper very interesting. The PA who treats me as a T2 let me bypass all the other stuff and go straight to Afrezza. She had never heard of it and I had to sell her on it but she was listening and gave it a shot and likes the big decrease in A1C. But the question is......does your insurance pay for it or are you going through Eagle Pharmacy and buying directly from MNKD? That's the difference. Most insurers will not pay if it doesn't follow their protocol. |
|
|
|
Post by winstonsmith on Nov 9, 2019 6:14:06 GMT -5
Thanks Casper very interesting. The PA who treats me as a T2 let me bypass all the other stuff and go straight to Afrezza. She had never heard of it and I had to sell her on it but she was listening and gave it a shot and likes the big decrease in A1C. But the question is......does your insurance pay for it or are you going through Eagle Pharmacy and buying directly from MNKD? That's the difference. Most insurers will not pay if it doesn't follow their protocol. I have Liberty HealthShare which isn't considered insurance and they don't pay for any prescriptions. I paid $200 a box directly to Eagle. |
|
|
|
Post by rfogel on Nov 9, 2019 9:07:45 GMT -5
Any idea how much each afrezza cartridge costs to manufacture? Matt Pfeiffer (Old CEO) said at full capacity Afrezza will generate 70% Profit Margins. Yes, but what would be the least they could charge before having to take a loss on each cartridge? |
|
|
|
Post by apidistra on Nov 9, 2019 9:56:44 GMT -5
Why would the company ever want to cut the price or, heaven forbid, in doing so sell at a loss on its flagship product that outclasses all the competition? No one sells a Porsche for the price of a Ford unless he needs the money badly. We've got plenty of cash.
|
|
|
|
Post by agedhippie on Nov 9, 2019 10:04:12 GMT -5
Your idea will not work. The ADA and Insurance companies has certain protocols and they have to follow them. The only way Afrezza will get clear approval is if they get a new classification. And that would be ULTRA RAPID. Then the insurance companies will cover immediately. ... Don't confuse features and benefits. Until Afrezza can prove superiority to RAA in large scale trial then it really doesn't matter what it is classed as. The name or even the action is a feature, but a cost effective superior outcome is a benefit and they will pay for that (or can be forced to - see the pump and CGM battles). If you want to see this done properly watch what Novo Nordisk and Eli Lilly do with Fiasp and Urli as they take the original non-inferior, result which is the price of entry, and build on that to make their insulins a first choice with insurers. |
|
|
|
Post by cedafuntennis on Nov 9, 2019 13:32:49 GMT -5
Why would the company ever want to cut the price or, heaven forbid, in doing so sell at a loss on its flagship product that outclasses all the competition? No one sells a Porsche for the price of a Ford unless he needs the money badly. We've got plenty of cash. You cannot compare cars which are very labor intensive to produce and maintain, to a powder drug which can be manufactured for peanuts in comparison. Totally different market dynamic here. I think that could work. Once the patient base increases drastically, even at lower revenue, the production cost will decrease drastically too, thus helping to increase the profits, this time with much more clients going forward. Like in chess, sacrifice the bishop to capture their queen in the next few moves. |
|
